 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              A meeting of the Board of Directors of Venus Remedies Ltd is scheduled to be held on 18.03.2017 to allot 9,00,000 equity shares on conversion of fully convertible warrants to Promoters on preferential basis and any other item with the permission of chair.
The trading window shall be closed for the dealing in the securities of the company listed at your exchange with effect from March 15, 2017 to March 20, 2017 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.98.2 as compared to the previous close of Rs. 98.75. The total number of shares traded during the day was 10875 in over 175 trades.
The stock hit an intraday high of Rs. 99.3 and intraday low of 97. The net turnover during the day was Rs. 1068780.